Foresight Acquisition said its shareholder meeting today was adjourned until Nov. 24, at which time a vote would be taken on the proposed merger with P3 Health Partners.
The SPAC said the meeting was adjourned to give stockholders “additional time to consider additional disclosure to be included in a supplement to the Proxy Statement.”
The deal gives P3 an enterprise value of about $2.3 billion. As announced in May, proceeds would consist of up to $316 million of cash held in Foresight’s trust, assuming no redemptions, and an additional $200 million PIPE.
P3 is a physician-led population health management company that supports providers, physicians, and practices in value-based systems of care and wellness. P3 is a portfolio company of Chicago Pacific Founders who provided P3’s initial and growth capital. Read more.
